Allogene Therapeutics Inc
NASDAQ:ALLO

Watchlist Manager
Allogene Therapeutics Inc Logo
Allogene Therapeutics Inc
NASDAQ:ALLO
Watchlist
Price: 2.72 USD -4.23% Market Closed
Market Cap: 568.8m USD
Have any thoughts about
Allogene Therapeutics Inc?
Write Note

Wall Street
Price Targets

ALLO Price Targets Summary
Allogene Therapeutics Inc

Wall Street analysts forecast ALLO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALLO is 9.78 USD with a low forecast of 4.55 USD and a high forecast of 14.7 USD.

Lowest
Price Target
4.55 USD
67% Upside
Average
Price Target
9.78 USD
260% Upside
Highest
Price Target
14.7 USD
440% Upside

ALLO Last Price Targets
Allogene Therapeutics Inc

The latest public price target was made on May 16, 2024 by Debjit Chattopadhyay from H.C. Wainwright , who expects ALLO stock to rise by 231% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Debjit Chattopadhyay
H.C. Wainwright
9 USD
Upside 231%
5 months ago
May 16, 2024
Allogene (ALLO) PT Lowered to $9 at H.C. Wainwright
StreetInsider
Kalpit Patel
B.Riley Financial
7 USD
Upside 157%
6 months ago
May 14, 2024
Allogene (ALLO) PT Lowered to $7 at B.Riley
StreetInsider
Debjit Chattopadhyay
H.C. Wainwright
Price Target 9 USD
Upside/Downside 231%
View Source
Kalpit Patel
B.Riley Financial
Price Target 7 USD
Upside/Downside 157%
View Source
Allogene Therapeutics Inc Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
47% Upside
VRTX
Vertex Pharmaceuticals Inc
6% Upside
ARX
Aroa Biosurgery Ltd
48% Upside
NTLA
Intellia Therapeutics Inc
328% Upside
VRDN
Viridian Therapeutics Inc
80% Upside
ARMP
Armata Pharmaceuticals Inc
163% Upside
084650
Labgenomics Co Ltd
83% Upside
IMRX
Immuneering Corp
569% Upside

Revenue
Forecast

Revenue Estimate
Allogene Therapeutics Inc

The compound annual growth rate of Allogene Therapeutics Inc's revenue for the next 3 years is 478%.

N/A
Past Growth
478%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Allogene Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Allogene Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALLO's stock price target?
Price Target
9.78 USD

According to Wall Street analysts, the average 1-year price target for ALLO is 9.78 USD with a low forecast of 4.55 USD and a high forecast of 14.7 USD.

What is Allogene Therapeutics Inc's Revenue forecast?
Projected CAGR
478%

The compound annual growth rate of Allogene Therapeutics Inc's revenue for the next 3 years is 478%.

Back to Top